Loading organizations...
§ Private Profile · Hsinchu City, Taiwan
Spirox is a technology company.
Spirox develops medical devices, focusing on solutions for nasal obstruction. The company’s primary product is the LATERA Absorbable Nasal Implant, designed to treat nasal-valve collapse. This minimally invasive implant supports the lateral nasal wall, aiming to improve airflow and breathing for individuals experiencing chronic nasal blockage. The technology offers a discreet and effective option for patients seeking relief from this common condition.
The company was founded in 2013 by Donald A. Gonzales, a distinguished Otolaryngologist. Dr. Gonzales identified a significant need for a dedicated and less invasive medical device to address the prevalent issue of nasal-valve collapse, drawing upon his clinical expertise to conceptualize a targeted solution that could be effectively deployed to improve patient outcomes.
Spirox’s LATERA implant primarily serves patients diagnosed with nasal obstruction due to structural weakness in the nasal valve. The company's vision centers on enhancing the quality of life for these individuals by providing an innovative, evidence-based treatment. By focusing on a specific, impactful medical need, Spirox aims to offer a durable and patient-friendly alternative to traditional surgical interventions.
Spirox has raised $64.0M across 2 funding rounds.
Spirox has raised $64.0M in total across 2 funding rounds.
Spirox Corporation (TWSE: 3055) is a Taiwan-based technology company founded in 1987 that provides integrated solutions for the semiconductor and FPD (flat panel display) industries, including IC testing, advanced packaging, inspection, and quality assurance equipment.[1][2][3] It offers products like automatic test equipment (ATE), wafer testing, optical inspection systems, laser tomography scanning (SpiroxLTS), and repair services, serving customers in Taiwan, China, and internationally with a focus on non-destructive defect inspection and process efficiency.[1][3] With approximately 120 employees and annual revenue of $86.3 million in 2025, Spirox partners with global leaders to deliver cost-lowering, efficiency-boosting technologies, evidenced by recent innovations like the SpiroxLTS for through-glass vias (TGV) and a power semiconductor reliability lab.[2][3]
The company demonstrates strong growth momentum through industry-first launches, such as the JadeSiC-NK non-destructive SiC defect inspection system in 2023 and the Asia-Pacific's first power semiconductor dynamic reliability lab in early 2025, amid rising demand from China's IC sector and automotive-grade verification needs.[3][5]
Spirox was founded in 1987 and is headquartered in Hsinchu City, Taiwan—a global semiconductor hub—with branches in Taipei, Kaohsiung, Shanghai, and Suzhou.[1][2] Early focus centered on partnering with worldwide suppliers to provide testing, packaging, and inspection solutions for Taiwan's burgeoning semiconductor industry, evolving over 30+ years into a comprehensive equipment provider known for smarter, competitive-edge technologies.[2][3] Pivotal moments include returning to profitability in 2020 amid ramping shipments into 2021, strong Chinese demand extending visibility into 2022, and recent expansions like the 2025 SpiroxLTS launch accelerating TGV mass production and the power semiconductor lab collaboration with SET GmbH (now part of NI).[3][5] Leadership includes Chairman Peter Chin (since 2022) and key directors like Jack Chen (since 2018).[1]
Spirox rides the explosive growth of advanced semiconductors, including SiC power devices for EVs/automotive, TGV for next-gen packaging, and China's expanding IC production amid global chip shortages.[3][5] Timing aligns with post-2020 recovery, where demand surged for testing/packaging gear, enabling Spirox's profitability rebound and order backlogs into 2022.[5] Market forces like Taiwan's dominance (Hsinchu ecosystem), U.S.-China tensions boosting regional suppliers, and AI/5G/EV-driven complexity favor its non-destructive, high-precision tools that cut costs and speed verification.[2][3] It influences the ecosystem by accelerating mass production (e.g., TGV, SiC) and providing Asia-Pacific labs, supporting local manufacturers' R&D and global competitiveness.[3]
Spirox is poised for sustained growth through 2026 and beyond, leveraging 2025 innovations like SpiroxLTS and reliability labs to capture shares in high-margin SiC, TGV, and power semis amid EV/AI booms.[3] Trends like non-destructive inspection mandates, China localization, and advanced packaging complexity will shape its path, potentially driving revenue past $100M with expanded partnerships.[2][5] Its influence may evolve from regional distributor to global innovator, solidifying Taiwan's semiconductor edge—echoing its 1987 roots in efficient, integrated solutions that power today's tech boom.[2][3]
Spirox has raised $64.0M across 2 funding rounds. Most recently, it raised $45.0M Series C in March 2016.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 19, 2010 | Synerchip | $10.5M Series C | JAFCO Asia, PAC Link Ventures | David LEE, Magic Fund, Shinden |
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Mar 1, 2016 | $45M Series C | JIM Momtazee | 5AM Ventures, Aisling Capital, Venrock, Aisling Capital, Aperture Venture Partners, HealthQuest Capital | Announced |
| Apr 1, 2015 | $19M Series B | Venrock, Aftab Kherani | 5AM Ventures, Aisling Capital, Aperture Venture Partners, Correlation Ventures, Western Technology Investment | Announced |
Spirox has raised $64.0M in total across 2 funding rounds.
Spirox's investors include Jim Momtazee, 5AM Ventures, Aisling Capital, Venrock, Aperture Venture Partners, HealthQuest Capital, Aftab Kherani, Correlation Ventures, Western Technology Investment.